Cell Cycle · 2014 · 24 citations · 29 references
Life SciencesBiochemistryMolecular BiologyApoptosisCell SignalingSignal TransductionApoptosis In CancerApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingCaspase ActivationDeath ReceptorsApoptosis Regulation By PhosphatasesApoptosis Signaling PathwaysCell Death Signaling PathwaysDeath Ligand ResistanceProtein Degradation ResistanceRegulation By E3 Ubiquitin LigasesResistance To Death Receptor SignalingTrail-mediated Apoptosis
Protein phosphatase 2A (PP2A) is the major serine-threonine phosphatase that regulates a number of cell signaling pathways. PP2A activity is controlled partially through protein degradation; however, the underlying mechanism is not fully understood. Here we show that PP2A/C, a catalytic subunit of PP2A, is degraded by the Cullin3 (Cul3) ligase-mediated ubiquitin-proteasome pathway. In response to death receptor signaling by tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL), PP2A/C, caspase-8 and Cul3, a subunit of the cullin family of E3 ligases, are recruited into the death-inducing signaling complex (DISC) where the Cul3 ligase targets PP2A/C for ubiquitination and subsequent degradation. Functionally, knockdown of PP2A/C expression by siRNA or pharmacological inhibition of PP2A activity increases TRAIL-induced apoptosis. In cancer cells that have developed acquired TRAIL resistance, PP2A phosphatase activity is increased, and PP2A/C protein is resistant to TRAIL-induced degradation. Thus, this work identifies a new mechanism by which PP2A/C is regulated by Cul3 ligase-mediated degradation in response to death receptor signaling and suggests that inhibition of PP2A/C degradation may contribute to resistance of cancer cells to death receptor-induced apoptosis.
29
Identification and characterization of a new member of the TNF family that induces apoptosis
Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Maccon Keane, Seth A. Ettenberg, Marion M. Nau et al. · PubMed · 1999 · 557 citations